Evidence map›Paper›PMID 40820054›Full record

ArticleClinical and experimental medicine2025

Machine learning-based prediction of gastroesophageal junction cancer using electronic medical records.

Meng Qian, Ying Chen, Xiaofen Wu, Zhenxiang Wang, Ye Chen, Yan Zhang, Bo Li, Huihui Sun, Shuchang Xu

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meng Qian *Department of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Ying Chen *Department of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Xiaofen WuDepartment of Information, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Zhenxiang WangDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Ye ChenDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Yan ZhangDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Bo LiDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China.
Huihui SunDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China. s-haijie@163.com.
Shuchang XuDepartment of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, China. xschang@163.com.

Funding

Science and Technology Innovation Action Plan of STCSM 22DZ2203900Shanghai Informatization Development Special project 202001003Shanghai Municipal Science and Technology Project 21Y11908500the National Natural Science Foundation of China (grant No. 81974067), Clinical Research Plan of SHDC SHDC2022CRT004
6 · The paper itself

Abstract

Discriminating whether esophageal-related symptoms result from gastroesophageal junction cancer (GEJC) is challenging in clinical practice. This study aimed to develop and validate a tool to predict the likelihood of GEJC in patients with esophageal-related symptoms. The electronic medical record system was accessed to identify patients diagnosed with GEJC or gastroesophageal reflux disease (GERD) at our hospital between 2009 and 2023. Predictive variables included demographic characteristics, symptoms, and laboratory results. After propensity score matching, significant features of GEJC were screened using the least absolute shrinkage and selection operator (LASSO), Boruta, and logistic regression analysis. Patients were randomly divided into training and test cohorts in a 2:1 ratio. Four machine learning models were trained and validated for predicting GEJC patients. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), residual analysis, calibration curve, and Brier score. Additionally, Shapley Additive exPlanations analysis was used to explain the importance of different features. After matching, 401 GEJC patients were enrolled and compared with 401 GERD controls. Using the variables identified by LASSO, Boruta, and logistic regression analysis, we constructed four machine learning models including random forest, generalized linear model, extreme gradient boosting (XGBoost), and support vector machine. XGBoost exhibited better predictive performance with an AUC of 0.907 in the test cohort. The calibration curve of the XGBoost model also demonstrated strong consistency with a Brier score of 0.088. Body mass index, hemoglobin, age, reflux, and dysphagia were found to be significant influences on the model output. We developed a well-performing model for predicting GEJC using electronic medical records. Implementing this prediction tool in clinical practice may guide diagnostic strategies and provide appropriate interventions.

Indexed as

Electronic Health RecordsEsophageal NeoplasmsEsophagogastric JunctionMachine LearningStomach NeoplasmsAdultAgedFemaleGastroesophageal RefluxHumansLogistic ModelsMaleMiddle AgedROC CurveElectronic medical recordsGastroesophageal junction cancerGastroesophageal reflux diseaseMachine learningPrediction model

Identifiers

PMID40820054
PMCPMC12358332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.